Intrathecal lidocaine neurotoxicity: Combination with bupivacaine and ropivacaine and effect of nerve growth factor

Life Sciences

Volumn 112, Issue 1-2, 2014, Pages 10-21

  Zhao, Guangyi ^a   Ding, Xudong ^a   Guo, Yao ^a   Chen, Weimin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Bupivacaine; Caspase; Lidocaine; Local anesthetics; Nerve growth factor; Neurotoxicity; Ropivacaine

Indexed keywords

BUPIVACAINE; CASPASE 3; LIDOCAINE; MYELIN; NERVE GROWTH FACTOR; ROPIVACAINE; AMIDE; DRUG COMBINATION; LOCAL ANESTHETIC AGENT; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; MOTOR PERFORMANCE; MYELIN SHEATH; NERVE FIBER; NERVE FIBER DEGENERATION; NEUROTOXICITY; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; SPINAL CORD DORSAL HORN; SPINAL CORD LESION; WHITE MATTER; ANIMAL; DRUG COMBINATION; DRUG EFFECTS; GENETICS; INTRASPINAL DRUG ADMINISTRATION; MALE; METABOLISM; NEUROTOXICITY SYNDROMES; PATHOPHYSIOLOGY; SPINAL CORD; SPRAGUE DAWLEY RAT;

AMIDES; ANESTHETICS, LOCAL; ANIMALS; APOPTOSIS; BUPIVACAINE; CASPASE 3; DOWN-REGULATION; DRUG COMBINATIONS; INJECTIONS, SPINAL; LIDOCAINE; MALE; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 84908614110     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.07.003     Document Type: Article

References (33)

1. Blais M, Levesque P, Bellenfant S, Berthod F. Nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3 and glial-derived neurotrophic factor enhance angiogenesis in a tissue-engineered in vitro model. Tissue Eng Part A 2013;19(15-16):1655-64.
2. Camorcia M, Capogna G, Columb MO. Estimation of the minimum motor blocking potency ratio for intrathecal bupivacaine and lidocaine. Int J Obstet Anesth 2008;17(3):223-7.
3. Cao X, Tang C, Luo Y. Effect of nerve growth factor on neuronal apoptosis after spinal cord injury in rats. Chin J Traumatol 2002;5(3):131-5.
4. Cherng CH, Wong CS, Wu CT, Yeh CC. Glutamate release and neurologic impairment after intrathecal administration of lidocaine and bupivacaine in the rat. Reg Anesth Pain Med 2011;36(5):452-6.
5. Cuvillon P, Nouvellon E, Ripart J, Boyer JC, Dehour L, Mahamat A, et al. A comparison of the pharmacodynamics and pharmacokinetics of bupivacaine, ropivacaine (with epinephrine) and their equal volume mixtures with lidocaine used for femoral and sciatic nerve blocks: a double-blind randomized study. Anesth Analg 2009;108(2):641-9.
6. Eberhart LH, Morin AM, Kranke P, Geldner G, Wulf H. Transient neurologic symptoms after spinal anesthesia. A quantitative systematic overview (meta-analysis) of randomized controlled studies. Anaesthesist 2002;51(7):539-46.
7. Eckert S, Standl T. Single-dose spinal anesthesia with a mixture of isobaric bupivacaine 0. 5% and hyperbaric mepivacaine 4%. Anaesthesist 1997;46(2):121-5.
8. Hampl KF, Heinzmann-Wiedmer S, Luginbuehl I, Harms C, Seeberger M, Schneider MC, et al. Transient neurologic symptoms after spinal anesthesia: a lower incidence with prilocaine and bupivacaine than with lidocaine. Anesthesiology 1998;88(3):629-33.
9. Iida H, Watanabe Y, Dohi S, Ishiyama T. Direct effects of ropivacaine and bupivacaine on spinal pial vessels in canine. Assessment with closed spinal window technique. Anesthesiology 1997;87(1):75-81.
10. Jiang H, Tian S, Zeng Y, Shi J. Nerve growth factor inhibits Gd(3+)-sensitive calcium influx and reduces chemical anoxic neuronal death. J Huazhong Univ Sci Technolog Med Sci 2008;28(4):379-82.
11. Johnson ME. Potential neurotoxicity of spinal anesthesia with lidocaine. Mayo Clin Proc 2000;75(9):921-32.
12. Johnson ME, Saenz JA, DaSilva AD, Uhl CB, Gores GJ. Effect of local anesthetic on neuronal cytoplasmic calcium and plasma membrane lysis (necrosis) in a cell culture model. Anesthesiology 2002;97(6):1466-76.
13. Johnson ME, Uhl CB, Spittler KH, Wang H, Gores GJ. Mitochondrial injury and caspase activation by the local anesthetic lidocaine. Anesthesiology 2004;101(5):1184-94.
14. Kallio H, Snall EV, Tuomas CA, Rosenberg PH. Combination of hyperbaric lidocaine and ropivacaine in spinal anaesthesia for day surgery. Eur J Anaesthesiol 2006;23(7):568-73.
15. Kanai A, Hiruma H, Katakura T, Sase S, Kawakami T, Hoka S. Low-concentration lidocaine rapidly inhibits axonal transport in cultured mouse dorsal root ganglion neurons. Anesthesiology 2001;95(3):675-80.
16. Kristensen JD, Karlsten R, Gordh T. Spinal cord blood flow after intrathecal injection of ropivacaine: a screening for neurotoxic effects. Anesth Analg 1996;82(3):636-40.
17. Kristensen JD, Karlsten R, Gordh T. Spinal cord blood flow after intrathecal injection of ropivacaine and bupivacaine with or without epinephrine in rats. Acta Anaesthesiol Scand 1998;42(6):685-90.
18. Lee SJ, Bai SJ, Lee JS, Kim WO, Shin YS, Lee KY. The duration of intrathecal bupivacaine mixed with lidocaine. Anesth Analg 2008;107(3):824-7.
19. Lirk P, Haller I, Colvin HP, Frauscher S, Kirchmair L, Gerner P, et al. In vitro, lidocaine-induced axonal injury is prevented by peripheral inhibition of the p38 mitogen-activated protein kinase, but not by inhibiting caspase activity. Anesth Analg 2007;105(6):1657-64. [table of contents].
20. Liu SS, McDonald SB. Current issues in spinal anesthesia. Anesthesiology 2001;94(5):888-906.
21. Llado J, Haenggeli C, Maragakis NJ, Snyder EY, Rothstein JD. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injuredmotor neurons through the secretion of neurotrophic factors. Mol Cell Neurosci 2004;27(3):322-31.
22. Manni L, Rocco ML, Bianchi P, Soligo M, Guaragna M, Barbaro SP, et al. Nerve growth factor: basic studies and possible therapeutic applications. Growth Factors 2013;31(4):115-22.
23. Nishiyama T. Comparison of themotor and sensory block by ropivacaine and bupivacaine in combination with lidocaine in interscalene block. Med Arh 2012;66(5):315-7.
24. Radwan IA, Saito S, Goto F. Growth cone collapsing effect of lidocaine on DRG neurons is partially reversed by several neurotrophic factors. Anesthesiology 2002a;97(3):630-5.
25. Radwan IA, Saito S, Goto F. The neurotoxicity of local anesthetics on growing neurons: a comparative study of lidocaine, bupivacaine, mepivacaine, and ropivacaine. Anesth Analg 2002b;94(2):319-24. [table of contents].
26. Sakura S, Kirihara Y, Muguruma T, Kishimoto T, Saito Y. The comparative neurotoxicity of intrathecal lidocaine and bupivacaine in rats. Anesth Analg 2005;101(2):541-7. [table of contents].
27. Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 2001;24:1217-81.
28. Takenami T, Yagishita S, Murase S, Hiruma H, Kawakami T, Hoka S. Neurotoxicity of intrathecally administered bupivacaine involves the posterior roots/posterior white matter and is milder than lidocaine in rats. Reg Anesth Pain Med 2005;30(5):464-72.
29. Takenami T, Wang G, Nara Y, Fukushima S, Yagishita S, Hiruma H, et al. Intrathecally administered ropivacaine is less neurotoxic than procaine, bupivacaine, and levobupivacaine in a rat spinal model. Can J Anaesth 2012;59(5):456-65.
30. Werdehausen R, Braun S, Essmann F, Schulze-Osthoff K, Walczak H, Lipfert P, et al. Lidocaine induces apoptosis via the mitochondrial pathway independently of death receptor signaling. Anesthesiology 2007;107(1):136-43.
31. Yamashita A, Matsumoto M, Matsumoto S, Itoh M, Kawai K, Sakabe T. A comparison of the neurotoxic effects on the spinal cord of tetracaine, lidocaine, bupivacaine, and ropivacaine administered intrathecally in rabbits. Anesth Analg 2003;97(2):512-9. [table of contents].
32. Yazicioglu D, Akkaya T, Kulacoglu H. Addition of lidocaine to bupivacaine for spinal anaesthesia compared with bupivacaine spinal anaesthesia and local infiltration anaesthesia. Acta Anaesthesiol Scand 2013;57(10):1313-20.
33. Zaric D, Pace NL. Transient neurologic symptoms (TNS) following spinal anaesthesia with lidocaine versus other local anaesthetics. Cochrane Database Syst Rev 2009(2):CD003006.